Drug intelligence / Profile preview

paracetamol + diphenhydramine

Development stage
Unknown
Lead developer
LIFEPharma
Modality
Small Molecules
Administration
Oral
01

Overview

Panalife Night is a combination pharmaceutical product developed and manufactured by LIFEPharma, primarily indicated for the temporary relief of pain and fever associated with difficulty sleeping. The formulation consists of paracetamol (acetaminophen), which serves as an analgesic and antipyretic, and diphenhydramine hydrochloride, a first-generation antihistamine with potent sedative properties. Paracetamol works by inhibiting prostaglandin synthesis in the central nervous system, thereby elevating the pain threshold and reducing fever. Diphenhydramine acts as a competitive antagonist at the H1 receptor and crosses the blood-brain barrier to induce drowsiness, making the combination suitable for nighttime relief of symptoms such as headache, backache, or musculoskeletal pain that disrupts sleep.

Brand names
Panalife Night
Other names
acetaminophen + diphenhydramine
02

Targets

HRH1 (Histamine H1 Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on paracetamol + diphenhydramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + diphenhydramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call